During clinical development, success depends on a sound regulatory strategy, and the preparation of complete and accurate CMC sections of regulatory filings. If CMC-regulatory obstacles are an important threat to the project, we will help develop technical and communication strategies to reduce risk. Alava team members are familiar with FDA and international regulatory procedures and expectations including electronic submission formats, and can work directly with regulators as needed.
